E.C. Approves Leo’s Delgocitinib Cream (Anzupgo) for CHE; FDA Accepts New Drug Application for Delgocitinib Cream in CHE
The European Commission (E.C.) has given its official nod to delgocitinib (Anzupgo, Leo Pharma) cream for adults with moderate to severe chronic hand eczema (CHE). In addition, the U.S. Food and Drug Administration has accepted LEO Pharma’s filing of a new drug application for delgocitinib cream in CHE. Delgocitinib, a topical pan-Janus kinase (JAK) inhibitor, […]